‘Avengers: Endgame’ is the biggest movie ever again, 7 years later—and it says a lot about the future of Hollywood’s IP machine

Disney and Marvel's "Avengers: Endgame Encore" grossed about $126 million worldwide, lifting the film's lifetime total to $2.9255 billion and narrowly reclaiming the all-time global box-office record from "Avatar" at $2.9237 billion. The rerelease fell more than 80% domestically in its second weekend, but its performance underscores durable demand for established franchise IP despite Marvel's post-pandemic decline. The 2026 summer domestic box office reached a record $4.76 billion, nearly 10% above 2019 before inflation adjustment, supported by both major franchises and several successful original films.

Analysis

The signal is less about incremental film revenue than restored scarcity value for event theatrical releases. For DIS, a successful franchise cycle can improve the economics of Disney+ acquisition/retention, consumer products, cruise and parks cross-selling; however, these downstream benefits accrue only if upcoming releases sustain audience satisfaction rather than merely monetize nostalgia. The rerelease itself is too small relative to Disney’s consolidated earnings to alter estimates, but it reduces the probability of another broad Marvel impairment cycle.

SONY has the cleaner near-term earnings sensitivity because its filmed-entertainment exposure is not diluted by parks, linear TV and streaming investment. A durable premium-theatrical environment supports film-library value, licensing leverage and margin recovery at Sony Pictures, while Disney retains more of the strategic upside from MCU ecosystem ownership. The key competitive implication is that studios with proven tentpoles gain bargaining power over exhibitors and promotional partners, potentially concentrating theatrical economics further around a limited number of franchises.

Consensus may over-extrapolate from isolated blockbuster outcomes into a sector-wide theatrical recovery. The relevant underwriting variable is not aggregate box office but hit concentration: a slate built around expensive franchise films can generate volatile returns if one title misses, and marketing costs can erase much of the upside from a merely solid gross. Over the next 1-3 months, opening-weekend pre-sales and audience-score durability for the year-end tentpoles matter more than rerelease performance; over 6-18 months, the test is whether franchise success translates into higher segment margins and streaming engagement rather than higher content spend.

Key Decisions for Investors

• Prefer SONY over DIS in a 3-6 month pair trade: long SONY / short DIS in equal dollar amounts if upcoming tentpole tracking remains strong. SONY offers more direct film operating leverage; exit if Sony Pictures guidance fails to improve or DIS demonstrates material streaming-margin upside that offsets its conglomerate dilution.
• Do not chase DIS solely on the rerelease. Establish a watch alert around Disney’s next earnings call for management disclosure of theatrical marketing spend, Disney+ engagement and content-impairment trends; upgrade only if management pairs franchise momentum with stable or lower content investment.
• For event-driven exposure, consider a small SONY position ahead of verified pre-sale data for major Sony-distributed releases rather than buying after opening-weekend headlines. Target a 2:1 upside/downside framework, with a stop on materially weak international pre-sales or a guidance cut in Pictures.
• Avoid broad exhibitor longs as a read-through. Premium franchise demand can coexist with weak non-event attendance and unfavorable film-rental terms; require evidence of sustained concession-per-patron growth and a broader release-calendar recovery before using AMC or CNK as downstream beneficiaries.